Ingersoll-Rand (India) Limited (INGERRAND.NS) Bundle
If you're tracking Ingersoll‑Rand Limited (INGERRAND.NS), this deep dive unpacks why a modest top‑line uptick - $1.72 billion in Q1 2025, up 2.8% from $1.67 billion a year earlier and $1.96 billion in Q3 2025 (a 5.1% YoY rise that beat estimates) - matters alongside sharper profit and cash signals: Adjusted EBITDA $544.6 million in Q3 2025 with a 27.9% margin, EPS gains such as +12.7% to $0.62 in Q3 2025 and an adjusted Q2 2025 EPS of $0.80 versus $0.61 est., but also pockets of stress including a Q1 2025 net income drop to $186.5 million from $202.2 million and a Q2 2025 non‑cash impairment driving a net loss; balance‑sheet dynamics include a liquidity cushion of $3.8 billion, free cash flow of $326 million in Q3 2025 (vs. $374 million prior year) and leverage drifting to 1.8x net debt/Adjusted EBITDA in Q3 2025 - while acquisitions (four deals for $176.4 million in Q1 2025 and $249 million deployed to M&A in Q3 2025) and a rising aftermarket mix (38.1% of revenue in Q1 2025) point to growth vectors you'll want to evaluate in the full article.
Ingersoll-Rand Limited (INGERRAND.NS) - Revenue Analysis
Ingersoll-Rand reported sequential and year-over-year revenue growth driven by its Industrial Technologies and Services segment, acquisitions and service mix shifts. Key headline figures show modest top-line expansion alongside mixed underlying volume performance and currency headwinds.- Q1 2025 revenue: $1.72 billion, up 2.8% from $1.67 billion in Q1 2024.
- Q3 2025 revenue: $1.96 billion, up 5.1% year-over-year and slightly above the $1.95 billion consensus estimate.
- Industrial Technologies & Services segment revenue (Q1 2025): $1.54 billion - the primary driver of company growth.
| Period | Total Revenue | YoY Change | Segment Highlight |
|---|---|---|---|
| Q1 2024 | $1.67B | - | Base |
| Q1 2025 | $1.72B | +2.8% | Industrial Tech & Services: $1.54B |
| Q3 2025 | $1.96B | +5.1% | Beat consensus ($1.95B) |
- Organic sales volume: decrease of $88.9 million in Q1 2025, indicating end-market or order softness in certain channels.
- Acquisitions: added $139.5 million to revenue in Q1 2025, a significant contributor to reported growth.
- Foreign currency: negative impact of $27.7 million on revenues in Q1 2025 due to currency translation headwinds.
- Aftermarket parts & services: comprised 38.1% of revenue in Q1 2025, up from 37.0% in Q1 2024, demonstrating higher recurring/installed-base sales contribution.
Ingersoll-Rand Limited (INGERRAND.NS) - Profitability Metrics
- Q1 2025: Net income attributable to Ingersoll-Rand decreased to $186.5 million (vs. $202.2 million in Q1 2024).
- Q2 2025: Reported a net loss of $115 million, driven by non-cash impairments; adjusted EPS was $0.80, ahead of the $0.61 estimate.
- Q3 2025: Adjusted EBITDA rose by $11.9 million to $544.6 million, with an adjusted EBITDA margin of 27.9% (slightly down from 28.6% in Q3 2024); EPS increased 12.7% to $0.62 (from $0.55 in Q3 2024).
| Quarter | Net Income / (Loss) (USD) | Adjusted EBITDA (USD) | Adj. EBITDA Margin | Adjusted EPS (USD) | Reported EPS / YoY % |
|---|---|---|---|---|---|
| Q1 2024 | $202.2M | - | - | - | - |
| Q1 2025 | $186.5M | - | - | - | - |
| Q2 2025 | ($115.0M) net loss | - | - | $0.80 (adjusted) | - |
| Q3 2024 | - | $532.7M (implied) | 28.6% | - | EPS $0.55 |
| Q3 2025 | - | $544.6M | 27.9% | - | EPS $0.62 (↑12.7% YoY) |
- Margin dynamics: adjusted EBITDA margin compression from 28.6% to 27.9% year-over-year in Q3 2025 indicates modest margin pressure despite higher absolute EBITDA.
- Volatility note: Q2 2025's $115M non-cash impairment produced headline net loss despite underlying adjusted profitability (adjusted EPS beat).
- EPS trajectory: adjusted EPS beats (Q2 2025) and YoY EPS growth (Q3 2025) support operational resilience even amid periodic charges.
Ingersoll-Rand Limited (INGERRAND.NS) - Debt vs. Equity Structure
Ingersoll-Rand's capital structure through 2025 shows a moderate leverage profile, strong liquidity and active shareholder returns alongside targeted M&A deployment. Key reported metrics and movements across the year:- Net debt-to-Adjusted EBITDA: 1.8x in Q3 2025 (up 0.1x YoY); 1.7x in Q2 2025 (down 0.3x YoY).
- Liquidity: cash and equivalents of $3.8 billion as of September 30, 2025.
- Capital allocation in Q3 2025: $249 million to M&A, $193 million to share repurchases, $8 million in dividends.
- Capital returned in Q2 2025: $201 million total (comprised of $193 million share repurchases and $8 million dividends).
- Interest expense: increased by 66% in Q1 2025 to $61.2 million, driven primarily by higher long‑term debt levels.
| Quarter | Net debt / Adjusted EBITDA | Liquidity (Cash & Equivalents) | M&A Deployment | Share Repurchases | Dividends | Interest Expense |
|---|---|---|---|---|---|---|
| Q1 2025 | - | - | - | - | - | $61.2M (↑66% YoY) |
| Q2 2025 | 1.7x (-0.3x YoY) | - | - | $193M | $8M | - |
| Q3 2025 (as of Sep 30, 2025) | 1.8x (+0.1x YoY) | $3.8B | $249M | $193M | $8M | - |
Ingersoll-Rand Limited (INGERRAND.NS) - Liquidity and Solvency
Ingersoll-Rand Limited's short-term and balance-sheet strength in 2025 shows mixed dynamics: robust overall liquidity and operating cash generation, alongside rising operating working capital and some year-over-year free cash flow pressure.- Q3 2025 cash flow from operating activities: $355 million.
- Q3 2025 free cash flow: $326 million (down from $374 million in Q3 2024).
- Q2 2025 free cash flow: $210 million, lower year-over-year.
- Current ratio: 2.29, indicating strong short-term coverage of liabilities.
- Total liquidity: $3.8 billion in Q3 2025.
- Operating working capital in Q3 2025: $1,736.4 million, up $317.8 million versus prior period (driven by inventories and receivables).
| Metric | Q2 2025 | Q3 2025 | Comparative / Notes |
|---|---|---|---|
| Operating cash flow | - | $355 million | Q3 generation |
| Free cash flow | $210 million | $326 million | Q3 down from $374M prior-year; Q2 also down YoY |
| Operating working capital | $1,418.6 million | $1,736.4 million | Increase of $317.8 million (inventories & AR) |
| Current ratio | - | 2.29 | Strong short-term liquidity |
| Total liquidity | - | $3.8 billion | Includes cash, equivalents, and available facilities |
- Cash generation remains positive, with Q3 operating cash flow of $355M supporting near-term obligations.
- Free cash flow contraction versus prior-year ($326M vs. $374M) and weak Q2 ($210M) highlight sensitivity to working capital swings and seasonal patterns.
- Operating working capital buildup (+$317.8M) signals inventory accumulation and higher receivables - pressure on cash conversion but potentially supporting revenue growth or supply-chain positioning.
- Ample total liquidity ($3.8B) and a current ratio of 2.29 provide a cushion for capex, M&A optionality, and debt service even with temporary working capital increases.
Ingersoll-Rand Limited (INGERRAND.NS) - Valuation Analysis
Ingersoll-Rand's recent quarters show mixed signals for valuation: strong margins and cash conversion on one hand, and headline non-cash charges on the other. Key recent metrics:- Q3 2025 adjusted EBITDA margin: 27.9% (down from 28.6% in Q3 2024)
- Q2 2025 adjusted EBITDA margin: 27.0%; free cash flow margin: 26.0%
- Q3 2025 reported net loss: $115 million, driven by non-cash impairments
- Q3 2025 EPS: $0.62, up 12.7% from $0.55 in Q3 2024
- Q2 2025 adjusted EPS: $0.80 vs. consensus estimate $0.61
- Q3 2025 net income (adjusted/underlying): surged 10% to $245.8 million, reflecting improved cost management and operational efficiency
| Metric | Q3 2024 | Q2 2025 | Q3 2025 |
|---|---|---|---|
| Adjusted EBITDA margin | 28.6% | 27.0% | 27.9% |
| Free cash flow margin | - | 26.0% | - |
| Reported Net Income (GAAP) | - | - | Net loss $115M |
| Adjusted/Underlying Net Income | - | - | $245.8M (+10% YoY) |
| EPS | $0.55 | Adjusted $0.80 | $0.62 |
- Operational strength: high EBITDA and FCF margins (27% and 26% respectively) support valuation multiples even if headline GAAP results are distorted by impairments.
- Earnings quality: the divergence between reported GAAP loss and rising adjusted earnings/EPS suggests investors should focus on adjusted operating results and cash conversion when valuing the business.
- Market expectations: Q2 adjusted EPS beating estimates ($0.80 vs $0.61) indicates potential upside to consensus forecasts, which can compress risk premia.
- One-time items risk: the $115M non-cash impairments in Q3 2025 create short-term volatility in book equity and headline EPS - adjust multiples accordingly.
- Comparable analysis: use EBITDA/FCF-centric multiples rather than GAAP EPS multiples until impairment effects normalize.
Ingersoll-Rand Limited (INGERRAND.NS) - Risk Factors
Recent quarterly results and balance-sheet movements highlight several risks investors should weigh when evaluating Ingersoll-Rand Limited (INGERRAND.NS).
- Volume and top-line pressure: organic sales volume declined by $88.9 million in Q1 2025, signaling demand softness in end markets or execution challenges.
- Profitability shocks: the company reported a net loss of $115 million in Q2 2025, driven in part by non-cash impairments; the same net loss figure was reported again in Q3 2025, also impacted by non-cash impairments.
- Leverage increase: net debt-to-Adjusted EBITDA leverage rose to 1.8x in Q3 2025, indicating higher financial leverage and reduced cushion for adverse cash-flow events.
- Working capital strain: operating working capital increased by $317.8 million in Q3 2025, reflecting higher inventories and accounts receivable and potential absorption of cash.
- Margin compression: adjusted EBITDA margin slipped to 27.9% in Q3 2025 from 28.6% in Q3 2024, showing slight deterioration in underlying profitability.
| Metric | Period | Value | Impact |
|---|---|---|---|
| Organic sales volume decline | Q1 2025 | $88.9 million | Top-line weakness |
| Net loss | Q2 2025 | $115 million | Non-cash impairments |
| Net loss | Q3 2025 | $115 million | Non-cash impairments |
| Net debt / Adjusted EBITDA | Q3 2025 | 1.8x | Higher leverage |
| Operating working capital change | Q3 2025 | +$317.8 million | Higher inventories & AR |
| Adjusted EBITDA margin | Q3 2025 vs Q3 2024 | 27.9% vs 28.6% | Margin compression |
Key risk-drivers to monitor quarter-to-quarter include continued impairment charges, further increases in net debt leverage, inventory build or receivables extensions that prolong cash conversion, and any sustained demand weakness reflected in organic volume trends. For broader company background and context, see Ingersoll-Rand (India) Limited: History, Ownership, Mission, How It Works & Makes Money
Ingersoll-Rand Limited (INGERRAND.NS) - Growth Opportunities
Ingersoll-Rand Limited (INGERRAND.NS) strengthened its inorganic and organic growth pathways across 2025 through targeted acquisitions, steady liquidity and focused deployment of capital into Industrial Technologies and Services. Recent deal activity and capital availability position the company to expand product breadth, accelerate entry into Asia-Pacific specialty markets and capture aftermarket/service revenue.- Q1 2025: Four smaller acquisitions completed totaling $176.4 million, all in the Industrial Technologies and Services segment.
- Q2 2025: Closed on Lead Fluid (China) - a strategic purchase to bolster advanced fluid handling capability and access Chinese OEM & aftermarket channels.
- Q3 2025: Closed on Dave Barry Plastics - adds custom clean-room solutions for semiconductor, pharma and high-tech end markets.
- Q3 2025: Deployed $249 million to M&A activity, signaling continued focus on inorganic growth.
- Q3 2025: Reported $9.5 million in incremental revenue from recent acquisitions, demonstrating initial revenue traction.
- Q3 2025: Maintained a strong liquidity position of $3.8 billion, supporting near-term tuck-ins, integration and working capital needs.
| Transaction / Quarter | Target | Deal Value (USD) | Segment | Immediate Revenue Contribution (Q3 2025) | Strategic Rationale |
|---|---|---|---|---|---|
| Q1 2025 - Acq Bundle | Four smaller targets | $176.4M (total) | Industrial Technologies & Services | - | Scale, product portfolio extension, regional aftermarket growth |
| Q2 2025 | Lead Fluid (China) | Not disclosed (closed) | Fluid handling | - | Access to Chinese market, advanced fluid tech, OEM integration |
| Q3 2025 | Dave Barry Plastics | Not disclosed (closed) | Clean room solutions | - | Entry into semiconductor/pharma supply chain, higher-margin solutions |
| Q3 2025 | Various M&A | $249M (deployment) | Multiple | $9.5M (reported) | Ongoing tuck-ins to accelerate revenue and cross-sell |
| Liquidity (Q3 2025) | Cash & equivalents / Availability | $3.8B | Corporate | - | Financial flexibility for acquisitions, buybacks, capex |
- Integration priorities: capture cross-sell, harmonize supply chains, extract cost synergies and preserve specialized engineering talent from targets.
- Market expansion levers: aftermarket services, subscription/recurring revenue for equipment service, and penetration of high-growth end markets (semiconductor, pharma, industrial automation).
- Capital allocation approach: balance between tuck-in M&A ($249M deployed in Q3 2025), selective larger deals, and preserving $3.8B liquidity to avoid over-leveraging while maintaining optionality.

Ingersoll-Rand (India) Limited (INGERRAND.NS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.